Lyso-phosphatidylethanol detected by LC-MS/MS as a potential new marker for alcohol consumption

Abstract

Alcohol biomarkers are able to reflect the degree of recent or long-term alcohol consumption, covering different windows of detection. Phosphatidylethanols (PEths) are an emerging group of direct alcohol biomarkers that are widely applied in clinical and forensic applications. Their quantification can provide insight into an individual's drinking behaviour. Here, we present a new sub-class of yet unknown PEth species, LysoPEths, which are structurally related to PEth, but miss one fatty acyl chain. LysoPEths can be either a degradation product of PEth or a product of transesterification of lyso-phosphatidylcholine (LysoPC) with ethanol. To set up an analytical method, LysoPEth 16:0 was synthesised from PC 16:0/18:1 and characterised by LC-MS/MS, using an enzymatic method: phospholipase D (PLD), followed by phospholipase A₂ (PLA₂). Then, an LC-MS/MS method in MRM mode for LysoPEth 16:0 with additional LysoPEth species (LysoPEth 18:1, LysoPEth 18:2, and LysoPEth 20:4) and PEth 16:0/20:4 was developed. By incubation of freshly sampled venous blood of a teetotaller with ethanol at different concentrations, the formation of LysoPEth in parallel to PEth was investigated. With increasing ethanol concentrations, LysoPEth 16:0 was formed besides the known PEth species (PEth 16:0/18:1, PEth 16:0/18:2) for up to 72 h with LysoPEth concentrations being about three times lower than PEth concentrations. Storage of ethanol-free PEth-positive blood of an alcohol consumer at 37 °C showed that LysoPEth 16:0 concentrations increased, while PEth 16:0/18:1 concentrations decreased in the first 24 h for frozen/thawed blood, however not for freshly collected blood. Furthermore, LysoPEth 16:0 was detected in venous as well as lyophilised blood from clinical and forensic case work alongside with PEth 16:0/18:1, 16:0/18:2, and other PEth and LysoPEth species (PEth 16:0/20:4, LysoPEth 18:1, LysoPEth 18:2, and LysoPEth 20:4). LysoPEth 16:0 concentrations were found to be in linear correlation with PEth 16:0/18:1 (r²= 0.75).

Keywords

LC-MS/MS alcohol biomarker phosphatidylethanol method development blood,Dried Blood Spots LysoPEth

Get full access to this article

View all access options for this article.

References

Global status report on alcohol and health 2018. Geneva: World Health Organization, 2018.

Fischer

Maeder

Telser

. Volkswirtschaftliche Kosten von Sucht. Federal Office of Public Health (FOPH) CH, 2021.

Schröck

Thierauf-Emberger

Schürch

, et al. Phosphatidylethanol (PEth) detected in blood for 3 to 12 days after single consumption of alcohol—a drinking study with 16 volunteers. Int J Leg Med 2017; 131: 153–160.

Trius-Soler

Praticò

Gürdeniz

, et al. Biomarkers of moderate alcohol intake and alcoholic beverages: a systematic literature review. Genes Nutr 2023; 18: 7.

Andresen-Streichert

Müller

Glahn

, et al. Alcohol biomarkers in clinical and forensic contexts. Deutsches Aerzteblatt Int 2018; 115: 309–315.

Thon

Weinmann

Yegles

, et al. Direkte Ethanolmetaboliten als Biomarker für Alkoholkonsum: grundlagen und Anwendungen. Fortschr Neurol Psychiatr 2013; 81: 493–502.

Harris

Leggio

Farokhnia

. Blood biomarkers of alcohol use: a scoping review. Curr Addict Rep 2021; 8: 500–508.

Ekroos

Ejsing

Bahr

, et al. Charting molecular composition of phosphatidylcholines by fatty acid scanning and ion trap MS³ fragmentation. J Lipid Res 2003; 44: 2181–2192.

Gnann

Engelmann

Skopp

, et al. Identification of 48 homologues of phosphatidylethanol in blood by LC-ESI-MS/MS. Anal Bioanal Chem 2010; 396: 2415–2423.

10.

Luginbühl

Stöth

Schröck

, et al. Quantitative determination of phosphatidylethanol in dried blood spots for monitoring alcohol abstinence. Nat Protoc 2021; 16: 283–308.

11.

Cameron

Vuong

McWhinney

, et al. Prevalence of alcohol consumption in emergency presentations: novel approach using two biomarkers, ethanol and phosphatidyl-ethanol. Drug Alcohol Rev 2022; 42: 146–156.

12.

Schröck

Pfaffli

Konig

, et al. Application of phosphatidylethanol (PEth) in whole blood in comparison to ethyl glucuronide in hair (hEtG) in driving aptitude assessment (DAA). Int J Leg Med 2016; 130: 1527–1533.

13.

Stöth

Weinmann

Soravia

, et al. Evaluation of phosphatidylethanol elimination in alcohol use disorder patients undergoing withdrawal treatment. Alcohol Alcohol 2023; 58: 266–273. DOI:10.1093/alcalc/agad010

14.

Luginbühl

Van Uytfanghe

Stöth

, et al. Current evolutions, applications, and challenges of phosphatidylethanol analysis for clinical and forensic purposes. WIRES Forensic Sci 2022; 4: e1456.

15.

Luginbühl

Wurst

Stöth

, et al. Consensus for the use of the alcohol biomarker phosphatidylethanol (PEth) for the assessment of abstinence and alcohol consumption in clinical and forensic practice (2022 Consensus of Basel). Drug Test Anal 2022; 14: 1800–1802.

16.

Karlson

. Phospholipide, Glykolipide und Membranen. Kurzes Lehrbuch der Biochemie für Mediziner u Naturwissenschaftler. 10th ed. Stuttgart: Georg Thieme, 1977, p.215.

17.

D'Arrigo

Servi

. Synthesis of lysophospholipids. Molecules 2010; 15: 1354–1377.

18.

Steiner

Temme

Daldrup

. The potential of 18:1 LysoPEth as alcohol (abstinence) marker. In: 15 Gemeinsames Symposium Deutsche Gesellschaft für Verkehrspsychologie und Deutsche Gesellschaft für Verkehrsmedizin Bonn, 2019.

19.

Kinkaid

Wilton

. The hydrolysis of phosphatidyl-alcohols by phospholipases A(2) - effect of head group size and polarity. Biochem Pharmacol 1997; 54: 1331–1339.

20.

Croset

Brossard

Polette

, et al. Characterization of plasma unsaturated lysophosphatidylcholines in human and rat. Biochem J 2000; 345: 61–67.

21.

Tong

. Biochemical Characterization of ethanol modified phospholipids in saccharomyces cerevisiae. Singapore: National University of Singapore, 2014.

22.

Schröck

Henzi

Bütikofer

, et al. Determination of the formation rate of phosphatidylethanol by phospholipase D (PLD) in blood and test of two selective PLD inhibitors. Alcohol 2018; 73: 1–7.

23.

Dumitrascu

van de Lavoir

MCA

Neels

, et al. Stability of phosphatidylethanol 16:0/18:1 in authentic and spiked whole blood. Drug Test Anal 2021; 13: 1219–1222.

24.

Skråstad

Spigset

Aamo

, et al. Stability of phosphatidylethanol 16:0/18:1 in freshly drawn, authentic samples from healthy volunteers. J Anal Toxicol 2020; 45: 417–421.

25.

Lopez-Cruzan

Roache

Hill-Kapturczak

, et al. Pharmacokinetics of phosphatidylethanol 16:0/20:4 in human blood after alcohol intake. Alcohol: Clin Exp Res 2018; 42: 2094–2099.